{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:13:24Z","timestamp":1649096004851},"reference-count":0,"publisher":"Informa UK Limited","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BTT"],"DOI":"10.2147\/btt.s1800","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T02:47:22Z","timestamp":1281581242000},"page":"67","source":"Crossref","is-referenced-by-count":2,"title":["Current and future applications of the anti-IgE antibody omalizumab"],"prefix":"10.2147","author":[{"given":"Cristoforo","family":"Incorvaia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2008,3]]},"container-title":["Biologics: Targets & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=2366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T21:56:25Z","timestamp":1477864585000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/current-and-future-applications-of-the-anti-ige-antibody-omalizumab-peer-reviewed-article-BTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/btt.s1800","relation":{},"ISSN":["1177-5475"],"issn-type":[{"value":"1177-5475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}